Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Contraception in Illinois

This article was originally published in The Tan Sheet

Executive Summary

Drug stores in Illinois will be required to post signs listing the options available to customers who cannot get their prescriptions filled, according to a proposed rule announced by Gov. Rod Blagojevich March 27. Under the rule, pharmacies will be required to "provide a medically acceptable alternative drug, or, at the request of the patient, order the drug from their supplier, transfer the prescription to a different drug store, or return the prescription to the patient." The action stems from the state's allegation that a pharmacist in West Peoria lied to a healthcare provider who called in a prescription for emergency contraception, saying it was not available at the pharmacy when in fact it was. The state has launched a formal complaint against the pharmacy. In April, Blagojevich issued an emergency ruling making it illegal for pharmacists to refuse to dispense EC (1"The Tan Sheet" June 20, 2005, p. 11)...

You may also be interested in...



Plan B Illinois “Emergency Rule” Challenged In Pharmacist Suit

An Illinois "emergency rule" requiring pharmacists to dispense emergency contraceptive Plan B violates the state's Health Care Right of Conscience Act, according to a suit filed in Whiteside County, Ill. court June 8

Simplified Clinical Trial Transparency Rules To Go Live In The EU In June

A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules. 

Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff

Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099233

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel